Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Evoke Pharma: Q1 Earnings Insights

Evoke Pharma (NASDAQ:EVOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Evoke Pharma missed estimated earnings by 75.0%, reporting an EPS of $-0.07 versus an estimate of $-0.04.

Revenue was up $327.96 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 12.82% drop in the share price the next day.

Here's a look at Evoke Pharma's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.08 -0.07 -0.08 -0.06
EPS Actual -0.06 -0.06 -0.07 -0.08
Revenue Estimate 510.00K 380.00K 150.00K 830.00K
Revenue Actual 360.57K 930.45K 236.63K 90.42K

To track all earnings releases for Evoke Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.